Skip to main content
OpenTrials
Completed

NCT Number: NCT02231957

Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions

There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vaccination

Age range

11 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NewYork-Presbyterian Hospital/Columbia University Medical Center

New York, 10032, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Parent with

  • adolescent aged 11-17 years;
  • adolescent with ≥1 chronic medical condition;
  • adolescent with clinic visit in last 12 months;
  • cell phone number listed in hospital registration system

Exclusion criteria

Parent who:

  • does not speak English or Spanish;
  • is unwilling to receive text message vaccine reminders;
  • anticipates moving from area in coming 12 months

Treatment and study plan

educational text message reminders

Other

Other names: educational text message vaccine reminders, education-embedded text message vaccine reminders

conventional text message reminders

Other

Other names: conventional text message vaccine reminders

Primary outcomes

  1. Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)

    Time frame: 12 weeks after intervention start

Secondary outcomes

  1. Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)

    Time frame: 4 weeks after intervention start

  2. Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)

    Time frame: 24 weeks after intervention start

  3. Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination

    Time frame: 4 weeks after intervention start

  4. Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination

    Time frame: 12 weeks after intervention start

  5. Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination

    Time frame: 24 weeks after intervention start

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • Pfizer

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2017
First posted
Sep 4, 2014
Registry last updated
Jan 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.